Citius Pharma (CTXR) Flexes Muscle in Business Update. Remains Our Top Idea.
Added to Watch List November 2019 @$0.55.
Named Our Top Idea in 2020 @$1.02.Remains Our Top Idea in 2021 @$1.80Cash has Risen From $3.3 Million...
Telehealth: Contactless Health Screening from Ehave (EHVVF) and VastMinz.
Contactless Health Screening
Ehave acquires License covering G-20 Countries for all Psychedelic use, AI-Powered Telehealth Technology To Capture Physiological Vitals From Vastmindz; Prepares To Run...
Dyadic (DYAI) Scores $10M deal with Sorrento Therapeutics (SNRE).
Share Price up 27% ($4.63 up $1.04) as Wall Street Sorts out the Terms of the Deal.
We've had a Long History With Dyadic Dating...
Hapbee (HAPB) Expands Leadership Team to Support Aggressive Growth Strategy
VANCOUVER, BC, Aug. 6, 2021 /CNW/ - Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) ("Hapbee" or the "Company"), the leading wearable, wellness technology company has announced the appointment...
Good Clinic Owned by Mitesco (MITI) In Star Tribune.
Former MinuteClinic Principals Open Walk-in Clinic in Minneapolis, Plan 3 More This Year. 50 Clinics Planned in Next Three Years.
LIVE QUOTE
Several principals behind...
With Hapbee (HAPBF) Who Needs, Drugs, Caffeine or Nicotine?
Record 1 Million Hours of Mood Stimulation Served by Hapbee (HAPBF).
TRADING AT THE LOWER END OF YEAR LONG CHANNEL, HAPBEE OFFER AN EXCELLENT ENTRY...
Cybin (CLXPF CYBN) Banks $30 Million Overnight.
Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Common Shares.
LIVE QUOTE
TORONTO, July 28, 2021--(BUSINESS WIRE)--Cybin Inc. (NEO: CYBN) (OTCQB:...
Incredible Ibogaine Psychedelic’s Testimonial
TIME MAGAZINEIn 2013, Marcus retired from the military. But life as a civilian only made his depression, anger, headaches, anxiety, alcoholism, impulsivity and violent...
Are Psychedelics the New Prozac?
Amidst a national epidemic of opioid abuse, and suicides the need for new therapeutics has gained greater urgency. In it's first step to meet this...
Cybin (CLXPF CYBN) Gets $8.00 Price Target From H.C. Wainwright.
Advancing Multiple Psychedelics in Multiple Indications; Initiating With a Buy and $8 Price Target.
REPORT
LIVE QUOTE
INVESTOR DECK